Hofseth Biocare (Norway) Today
| HBC Stock | NOK 2.20 0.05 2.33% |
Performance0 of 100
| Odds Of DistressLess than 16
|
Hofseth Biocare is selling for 2.20 as of the 23rd of April 2024. This is a 2.33% increase since the beginning of the trading day. The stock's lowest day price was 2.07. Hofseth Biocare has less than a 16 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Hofseth Biocare ASA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Hofseth BioCare ASA, a biotech company, offers value added biomarine ingredients and finished products for human consumption and pet in Norway. The company was founded in 2000 and is headquartered in lesund, Norway. HOFSETH BIOCARE operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. The company has 395.08 M outstanding shares. More on Hofseth Biocare ASA
Moving together with Hofseth Stock
| 0.77 | ULTI | Ultimovacs ASA | PairCorr |
| 0.71 | AZT | Arcticzymes Technologies | PairCorr |
| 0.78 | CIRCA | Circa Group AS | PairCorr |
| 0.84 | BGBIO | Bergenbio ASA | PairCorr |
| 0.82 | EXTX | Exact Therapeutics | PairCorr |
Moving against Hofseth Stock
| 0.88 | KOG | Kongsberg Gruppen ASA Earnings Call This Week | PairCorr |
| 0.45 | DNB | DnB ASA Earnings Call Today | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Hofseth Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hofseth Biocare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hofseth Biocare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Hofseth Biocare ASA (HBC) is traded on Oslo Stock Exchange in Norway and employs 9 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hofseth Biocare's market, we take the total number of its shares issued and multiply it by Hofseth Biocare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hofseth Biocare ASA operates under Healthcare sector and is part of Biotechnology industry. The entity has 395.08 M outstanding shares.
Hofseth Biocare ASA has accumulated about 36.52 M in cash with (61.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Check Hofseth Biocare Probability Of Bankruptcy
Ownership AllocationHofseth Biocare ASA has a total of 395.08 Million outstanding shares. Hofseth Biocare secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hofseth Ownership Details
Hofseth Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Hofseth Biocare jumping above the current price in 90 days from now is about 74.75%. The Hofseth Biocare ASA probability density function shows the probability of Hofseth Biocare stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Hofseth Biocare has a beta of 0.4054. This usually indicates as returns on the market go up, Hofseth Biocare average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Hofseth Biocare ASA will be expected to be much smaller as well. Additionally, hofseth Biocare ASA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Hofseth Biocare to move above the current price in 90 days from now is about 74.75 (This Hofseth Biocare ASA probability density function shows the probability of Hofseth Stock to fall within a particular range of prices over 90 days) .
Hofseth Biocare ASA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Hofseth Biocare market risk premium is the additional return an investor will receive from holding Hofseth Biocare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hofseth Biocare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Hofseth Biocare's alpha and beta are two of the key measurements used to evaluate Hofseth Biocare's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.36 | |||
| Standard Deviation | 3.42 | |||
| Variance | 11.7 | |||
| Risk Adjusted Performance | (0.03) |
Hofseth Stock Against Markets
Picking the right benchmark for Hofseth Biocare stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Hofseth Biocare stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Hofseth Biocare is critical whether you are bullish or bearish towards Hofseth Biocare ASA at a given time. Please also check how Hofseth Biocare's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hofseth Biocare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Hofseth Biocare Corporate Management
Elected by the shareholders, the Hofseth Biocare's board of directors comprises two types of representatives: Hofseth Biocare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hofseth. The board's role is to monitor Hofseth Biocare's management team and ensure that shareholders' interests are well served. Hofseth Biocare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hofseth Biocare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angelika Florvaag | Chief Officer | Profile | |
| Olav Flaten | Exec | Profile | |
| Tanja Schaffer | EVP GmbH | Profile | |
| Jon Odegard | Chief Officer | Profile | |
| Matt Mixter | Managing America | Profile | |
| Bomi Framroze | Chief Officer | Profile | |
| James Berger | Chief Officer | Profile |
How to buy Hofseth Stock?
Before investing in Hofseth Biocare, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Hofseth Biocare. To buy Hofseth Biocare stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Hofseth Biocare. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Hofseth Biocare stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Hofseth Biocare ASA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Hofseth Biocare ASA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Hofseth Biocare ASA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Hofseth Biocare ASA?
The danger of trading Hofseth Biocare ASA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Hofseth Biocare is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Hofseth Biocare. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Hofseth Biocare ASA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hofseth Biocare ASA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Hofseth Biocare ASA information on this page should be used as a complementary analysis to other Hofseth Biocare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Hofseth Stock analysis
When running Hofseth Biocare's price analysis, check to measure Hofseth Biocare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hofseth Biocare is operating at the current time. Most of Hofseth Biocare's value examination focuses on studying past and present price action to predict the probability of Hofseth Biocare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hofseth Biocare's price. Additionally, you may evaluate how the addition of Hofseth Biocare to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges |